Header Logo

Connection

BIYKEM BOZKURT to Male

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Male.
BIYKEM BOZKURT
Connection Strength
0.659
Male
  1. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021 08 10; 144(6):471-484.
    View in: PubMed
    Score: 0.028
  2. Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials. Circulation. 2020 02 04; 141(5):362-366.
    View in: PubMed
    Score: 0.025
  3. Heart Failure in Women. Methodist Debakey Cardiovasc J. 2017 Oct-Dec; 13(4):216-223.
    View in: PubMed
    Score: 0.021
  4. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol. 2017 06 15; 119(12):2030-2034.
    View in: PubMed
    Score: 0.021
  5. Usefulness of the Sum of Pulmonary Capillary Wedge Pressure and Right Atrial Pressure as a Congestion Index that Prognosticates Heart Failure Survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). Am J Cardiol. 2016 09 15; 118(6):854-859.
    View in: PubMed
    Score: 0.020
  6. Chagas cardiomyopathy is associated with higher incidence of stroke: a meta-analysis of observational studies. J Card Fail. 2014 Dec; 20(12):931-8.
    View in: PubMed
    Score: 0.017
  7. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct; 18(10):792-8.
    View in: PubMed
    Score: 0.015
  8. Hyperacute T-waves: Wolff-Parkinson-White pattern or acute coronary syndrome? J Emerg Med. 2013 Feb; 44(2):332-5.
    View in: PubMed
    Score: 0.015
  9. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
    View in: PubMed
    Score: 0.015
  10. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.014
  11. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol. 2013 Jun 20; 166(2):394-8.
    View in: PubMed
    Score: 0.014
  12. Guiding left ventricular lead positioning and refining ability to predict response and nonresponse to cardiac resynchronization therapy using dP/dt max: killing 3 birds with 1 high-fidelity wire? J Am Coll Cardiol. 2011 Sep 06; 58(11):1137-9.
    View in: PubMed
    Score: 0.014
  13. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.014
  14. Where do we currently stand with advice on hormone replacement therapy for women? Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan; 6(4):21-5.
    View in: PubMed
    Score: 0.013
  15. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
    View in: PubMed
    Score: 0.013
  16. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.013
  17. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
    View in: PubMed
    Score: 0.012
  18. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
    View in: PubMed
    Score: 0.012
  19. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Am J Cardiol. 2008 Nov 15; 102(10):1356-60.
    View in: PubMed
    Score: 0.011
  20. Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial. Nat Commun. 2026 07 30; 17(1).
    View in: PubMed
    Score: 0.010
  21. A qualitative study of goals of hospital care and health outcome goals among patients admitted for heart failure. Patient Educ Couns. 2026 Oct; 151:109769.
    View in: PubMed
    Score: 0.010
  22. Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2026 Aug; 32(8):2948-2958.
    View in: PubMed
    Score: 0.010
  23. Survodutide Once Weekly for the Treatment of Adults with Obesity. N Engl J Med. 2026 Aug 20; 395(8):776-787.
    View in: PubMed
    Score: 0.010
  24. "Real-world prognostic performance of different severe and advanced heart failure definitions: Data from the Swedish Heart Failure Registry". J Heart Lung Transplant. 2026 Sep; 45(9):1380-1393.
    View in: PubMed
    Score: 0.010
  25. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006 Apr 15; 97(8):1228-31.
    View in: PubMed
    Score: 0.010
  26. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005 Dec; 150(6):1233-9.
    View in: PubMed
    Score: 0.009
  27. Baseline characteristics in the SYNCHRONIZE?-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes. Diabetes Obes Metab. 2026 02; 28(2):1490-1498.
    View in: PubMed
    Score: 0.009
  28. Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE?-1). Diabetes Obes Metab. 2026 01; 28(1):337-346.
    View in: PubMed
    Score: 0.009
  29. Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry. Eur J Heart Fail. 2025 Nov; 27(11):2410-2421.
    View in: PubMed
    Score: 0.009
  30. Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure. JACC Heart Fail. 2025 Oct; 13(10):102515.
    View in: PubMed
    Score: 0.009
  31. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus. ESC Heart Fail. 2025 Jun; 12(3):1818-1831.
    View in: PubMed
    Score: 0.009
  32. Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints. J Cardiovasc Magn Reson. 2025; 27(1):101121.
    View in: PubMed
    Score: 0.009
  33. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J Card Fail. 2025 06; 31(6):881-891.
    View in: PubMed
    Score: 0.009
  34. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
    View in: PubMed
    Score: 0.008
  35. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
    View in: PubMed
    Score: 0.008
  36. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 2003 Jan 15; 41(2):211-4.
    View in: PubMed
    Score: 0.008
  37. Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J Card Fail. 2002 Oct; 8(5):306-14.
    View in: PubMed
    Score: 0.008
  38. Sex Differences in Heart Failure. J Card Fail. 2022 03; 28(3):477-498.
    View in: PubMed
    Score: 0.007
  39. Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States. Am J Med. 2021 11; 134(11):1371-1379.e2.
    View in: PubMed
    Score: 0.007
  40. Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 06 15; 77(23):2960-2972.
    View in: PubMed
    Score: 0.007
  41. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001 Feb 27; 103(8):1044-7.
    View in: PubMed
    Score: 0.007
  42. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
    View in: PubMed
    Score: 0.007
  43. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension. 2020 11; 76(5):1350-1367.
    View in: PubMed
    Score: 0.007
  44. Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1.
    View in: PubMed
    Score: 0.006
  45. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020 03; 13(3):e006513.
    View in: PubMed
    Score: 0.006
  46. Impact of a Resident-Centered Interprofessional Quality Improvement Intervention on Acute Care Length of Stay. J Healthc Qual. 2019 Jul/Aug; 41(4):212-219.
    View in: PubMed
    Score: 0.006
  47. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.006
  48. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998 Apr 14; 97(14):1382-91.
    View in: PubMed
    Score: 0.006
  49. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.005
  50. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.005
  51. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
    View in: PubMed
    Score: 0.005
  52. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 10 06; 5(10).
    View in: PubMed
    Score: 0.005
  53. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016 09 27; 134(13):e282-93.
    View in: PubMed
    Score: 0.005
  54. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015 Oct 20; 66(16):1803-1812.
    View in: PubMed
    Score: 0.005
  55. Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T. Respir Res. 2015 Oct 16; 16:126.
    View in: PubMed
    Score: 0.005
  56. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.004
  57. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84.
    View in: PubMed
    Score: 0.004
  58. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015 Jan 01; 115(1):21-6.
    View in: PubMed
    Score: 0.004
  59. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail. 2014 Aug; 2(4):412-21.
    View in: PubMed
    Score: 0.004
  60. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.004
  61. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility. JAMA Surg. 2013 Dec; 148(12):1087-93.
    View in: PubMed
    Score: 0.004
  62. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24; 129(25 Suppl 2):S49-73.
    View in: PubMed
    Score: 0.004
  63. Transcatheter aortic valve replacement as a treatment for late apicoaortic conduit obstruction in a patient with severe aortic stenosis. Circulation. 2013 Mar 19; 127(11):e491-4.
    View in: PubMed
    Score: 0.004
  64. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012 Jun; 18(6):459-70.
    View in: PubMed
    Score: 0.004
  65. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13; 59(11):998-1005.
    View in: PubMed
    Score: 0.004
  66. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2.
    View in: PubMed
    Score: 0.004
  67. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
    View in: PubMed
    Score: 0.003
  68. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan; 4(1):53-8.
    View in: PubMed
    Score: 0.003
  69. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009 Jul 28; 54(5):422-8.
    View in: PubMed
    Score: 0.003
  70. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009 May; 88(3):154-159.
    View in: PubMed
    Score: 0.003
  71. Does the level of experience of residents affect outcomes of coronary artery bypass surgery? Ann Thorac Surg. 2009 Apr; 87(4):1127-33; discussion 1133-4.
    View in: PubMed
    Score: 0.003
  72. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008 Dec 16; 118(25):2803-10.
    View in: PubMed
    Score: 0.003
  73. The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg. 2008 Nov; 196(5):720-5.
    View in: PubMed
    Score: 0.003
  74. Does the use of bilateral internal mammary artery grafts impact survival of veterans undergoing coronary artery bypass surgery? Am J Surg. 2008 Nov; 196(5):726-31.
    View in: PubMed
    Score: 0.003
  75. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail. 2008 Sep; 14(7):590-5.
    View in: PubMed
    Score: 0.003
  76. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
    View in: PubMed
    Score: 0.003
  77. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007 Jan; 8(1):31-6.
    View in: PubMed
    Score: 0.003
  78. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002 Dec; 8(6):390-8.
    View in: PubMed
    Score: 0.002
  79. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
    View in: PubMed
    Score: 0.002
  80. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.002
  81. Progressive dehiscence and dynamic compression of an aortic root homograft: detection and characterization by transesophageal echocardiography. Am Heart J. 1996 Nov; 132(5):1070-3.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.